CLINICAL CASE OF A PATIENT WITH EXTREME HYPERTROPHIC CARDIOMYOPATHY AND RECURRENT IDIOPATHIC TRANSUDATIVE PERICARDIAL EFFUSION
暂无分享,去创建一个
[1] V. Kittipibul,et al. Idiopathic pericardial effusion in patients with hypertrophic cardiomyopathy , 2021, The International Journal of Cardiovascular Imaging.
[2] J. Jefferies,et al. Clinical Insights Into Heritable Cardiomyopathies , 2021, Frontiers in Genetics.
[3] B. Maron,et al. Global Burden of Hypertrophic Cardiomyopathy. , 2018, JACC. Heart failure.
[4] S. Kachboura,et al. Risk stratification in hypertrophic cardiomyopathy , 2018, Herz.
[5] T. Ryan,et al. The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[6] B. Iung,et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.
[7] A. Anastasakis,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[8] Y. Adler,et al. Management of pericardial effusion. , 2013, European heart journal.
[9] T. Sejersen,et al. Deletion in TNNI3 gene is associated with restrictive cardiomyopathy. , 2009, International journal of cardiology.
[10] C. Appleton,et al. Echocardiographic determination of mean pulmonary artery pressure. , 2003, The American journal of cardiology.